Publication | Open Access
Dystrophin is a tumor suppressor in human cancers with myogenic programs
161
Citations
32
References
2014
Year
Tumor BiologyMyogenic ProgramsMedicinePathologyTumor SuppressorCancer TreatmentOncologyRadiation OncologyHuman CancersCancer Research
| Year | Citations | |
|---|---|---|
2012 | 8.3K | |
1987 | 4.6K | |
1998 | 4.4K | |
2003 | 2.3K | |
1991 | 1.3K | |
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study Sebahattin Çirak, Virginia Arechavala‐Gomeza, Michela Guglieri, Exon SkippingUrologyDuchenne Muscular DystrophyPhase 2Medicine | 2011 | 852 |
2010 | 711 | |
1974 | 688 | |
2007 | 318 | |
2007 | 285 |
Page 1
Page 1